Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009570:Nitriles / Q000494:pharmacology*; D010647:Phenyl Ethers / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013015:Sotalol / Q000494:pharmacology; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014132:Trachea / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D009570:Nitriles; D010647:Phenyl Ethers; D011412:Propanolamines; D011941:Receptors, Adrenergic; D011433:Propranolol; D013015:Sotalol; D007545:Isoproterenol